| | 
Part, Chapter, Paragraph
1 I, 2. 4. 0(1) | EUROSTAT Newsrelease 19/2009, 13 February 2009. [accessed
2 I, 2. 10. 4(20)| Healthcare Confererence 13-15 June 2006, Minneapolis,
3 I, 3. 1 | the United Kingdom, and 12-13% in Italy and the Netherlands;
4 I, 3. 2 | EU.~ ~ ~In 1960, around 13 per cent of the world’s
5 II, 4. 1 | 65.3 years to 78.5 years (13.2 years gap) for men and
6 II, 4. 1 | 10.4 years to 24.1 years (13.7 years gap) for women,
7 II, 4. 1 | expectancies at birth is over 13 years for men and over 7
8 II, 4. 1 | reach 14.5 years for men and 13.7 years for women, highlighting
9 II, 4. 1 | Approach for the EU 2008-13” has as the first of its
10 II, 4. 2 | shows the contribution of 13 selected causes of death
11 II, 4. 2 | expectancy of men in 9 out of the 13 countries. In several countries,
12 II, 4. 2 | related mortality (cause 13 in table 3) had a negative
13 II, 4. 2 | for men in 7 out of the 13 selected countries the decline
14 II, 4. 2 | women even in 9 out of the 13 countries. For Polish men
15 II, 4. 2 | for men in 8 out of the 13 selected countries and for
16 II, 4. 2 | negative in 7 out of the 13 countries. As women started
17 II, 4. 2 | expectancy in 12 of the 13 countries. In 9 of these
18 II, 4. 3 | Journal of Public Health 13(3): 6-14.~ ~Robine, J.-M.,
19 II, 4. 3 | Journal of Public Health 2003; 13:6-14.~ ~Robine, J.-M., C.
20 II, 5. 2. 3 | Table 5.2.4. WHO-MONICA 13 EU population. Mean annual
21 II, 5. 2. 3 | from 87 to 68 per 100.000), 13% in Baltic Europe countries (
22 II, 5. 2. 7 | Project. Eur J Public Health 13: 55-60~European society
23 II, 5. 2. 7 | Cardiovasc Prev Rehabil 13:562–570.~Panico S, Palmieri
24 II, 5. 3. 9 | Strategies in Europe, 12 – 13 July 2007, Strategies on
25 II, 5. 3. 9 | Strategies in Europe, 12 – 13 July 2007, Strategies on
26 II, 5. 3. 9 | indicators. Eur J Public Health 13(3 Suppl):116-118.~ ~Parkin
27 II, 5. 4. 2 | LDL>2.6 mmol/l (>3 mmol/l)~13~Percent of diabetic subjects
28 II, 5. 4. 2 | BMI 25 kg/m2 , 30 kg/m2~13~Age at diagnosis of diabetes
29 II, 5. 4. 2 | creatinine in last 12 months~13~Percent of diabetic subjects
30 II, 5. 4. 3 | Results reported by OECD from 13 EU countries lead to a median
31 II, 5. 4. 6 | lifestyles. See Chapter 5.13. on overweight and obesity
32 II, 5. 4. 6 | control plans~In 2008, only 13 of the 27 EU Member States (
33 II, 5. 4. 8 | Clinical and Experimental 13(4), 245. 2001.~Boyle D,
34 II, 5. 5. 1 | prevalence of major depression is 13% in Western and Southern
35 II, 5. 5. 1 | projected lifetime prevalence 13-26% in the participating
36 II, 5. 5. 1 | people aged 50 and over in 13 EU Member States. They do
37 II, 5. 5. 1 | women (20%) than in men (13%) and increased with age.~ ~
38 II, 5. 5. 2 | This represents between 1.13 and 1.25 percent of the
39 II, 5. 5. 2 | the Hague Convention of 13 January 2000 on the International
40 II, 5. 5. 2 | article online, accessed on 13 December 2007)~ ~Cooper
41 II, 5. 5. 3 | adolescence in the age of 13 to 18; however, several
42 II, 5. 5. 3 | European adolescents between 13 and 16 years of age (3000
43 II, 5. 5. 3 | for 11-year-olds, 37% for 13-year-olds and 42% for 15-
44 II, 5. 5. 3 | in Europe by nutrition in 13-16 years adolescents across
45 II, 5. 5. 3 | ranks 1st and accounts for 13.7% of YLDs, followed by
46 II, 5. 5. 3 | optimal treatment compared to 13% with current intervention
47 II, 5. 5. 3 | N S W Public Health Bull 13(7):155-8.~Andlin-Sobocki
48 II, 5. 5. 3 | en.pdf; last accessed Dec 13, 2007.~European Commission (
49 II, 5. 5. 3 | en.htm; last accessed Dec 13, 2007.~European Commission (
50 II, 5. 5. 3 | last accessed Dec 13, 2007.~World Health Organization (
51 II, 5. 5. 3 | last accessed Dec 13, 2007.~World Health Organisation (
52 II, 5. 5. 3 | last accessed Dec 13, 2007.~World Health Organization (
53 II, 5. 5. 3 | last accessed Dec 13, 2007.~World Health Organization (
54 II, 5. 5. 3 | last accessed Dec 13, 2007.~World Health Organization (
55 II, 5. 5. 3 | idiopathic 1.7; symptomatic 13.6), 6.7 per 100,000 for
56 II, 5. 5. 3 | revisited. Epileptic Disord 6:3-13.~Gaitatzis A, Carroll K,
57 II, 5. 5. 3 | Neurosurg Psychiatry 69:13-17.~Nashef L, Fish DR, Garner
58 II, 5. 5. 3 | to 80% (Spain), between 13% (Italy) and 48% (UK) for
59 II, 5. 5. 3 | MS for the year 2005 was €13 billion, i.e., €27 per European
60 II, 5. 5. 3 | centers. Cephalalgia Hungarica 13:68-70.~Battaglia M, Kesselring
61 II, 5. 5. 3 | Lodz. Cephalalgia Hungarica 13:63-64.~Boiko A, Deomina
62 II, 5. 5. 3 | Danes with MS. Int MS J 13:66-71.~Buehler JW. Surveillance (
63 II, 5. 5. 3 | University. Cephalalgia Hungarica 13:47-48.~Jedlicka P (1989):
64 II, 5. 5. 3 | protocols. Annals of Neurology 13:227–231.~Poser S, Stickel
65 II, 5. 5. 3 | in Europe. Eur J Neurol 13: 700–722.~Pugliatti M, Rosati
66 II, 5. 5. 3 | multinational cost study. Mult Scler 13(8):1054-64. Erratum in:
67 II, 5. 5. 3 | Belgium. Neuroepidemiology 13:220-225.~Vukusic S, Van
68 II, 5. 5. 3 | from €2,500 (Estonia) – €13,000 (Switzerland) with an
69 II, 5. 5. 3 | Parkinson’s disease. Mov Disord 13(4):626-632.~Anderson C,
70 II, 5. 5. 3 | ascertainment of cases. Mov Disord 13(3):400-405.~Chrischilles
71 II, 5. 5. 3 | Parkinson’s disease. Mov Disord 13(3):406-413.~Clarke CE, Zobkiw
72 II, 5. 5. 3 | s disease. Eur J Neurol 13(11):1170-1185.~Hughes AJ,
73 II, 5. 5. 3 | Current opinion in neurology 13(4):427-430.~Tanner CM (2003):
74 II, 5. 6. 3 | incidence of RA range from 4–13 per 100,000 for adult males
75 II, 5. 6. 3 | 000 for adult males and 13-36 per 100,000 for adult
76 II, 5. 6. 3 | France 0.32% and Italy 0.13%. In women, the prevalence
77 II, 5. 6. 6 | Survey. Ann Rheum Dis 52:6-13~Bergman S, Herrstrom P,
78 II, 5. 7. 3 | transplantation: 60% and 13%, respectively.~Mortality
79 II, 5. 7. 7 | Engl J Med 2004 Sep 23;351(13):1296-305.~Gorodetskaya
80 II, 5. 7. 7 | implications. J Am Soc Nephrol 2002;13(Suppl 1):S37-S40.~McKenna
81 II, 5. 8. 3 | centres of 16 countries (13 EU and EFTA countries) collected
82 II, 5. 8. 3 | Netherlands was 6.5. for mild, 13.3 for moderate, 3.7 for
83 II, 5. 9. 2 | atopic eczema in 6-7 and 13-15 years old were assessed
84 II, 5. 9. 2 | and 304 679 children aged 13–14 years from 106 centres
85 II, 5. 9. 2 | them were among adults, 13 among children and two among
86 II, 5. 9. 3 | and 16.9% in children of 13.14 years of age), Romania (
87 II, 5. 9. 3 | older, while adolescents 13 to 14 years old presented
88 II, 5. 9. 3 | rhinitis varied between 13.5% and 23.6% (median 18.
89 II, 5. 9. 3 | 9.3) identified that in 13 of the 20 studies reviewed,
90 II, 5. 9. 3 | of age-group than in the 13–14 years of age-group: for
91 II, 5. 9. 3 | reported no changes); for the 13–14 years of age-group, 11
92 II, 5. 9. 4 | 6837 participants from 13 countries who previously
93 II, 5. 9. 4 | among 1450 children aged 13- to 14- and living in Brescia,
94 II, 5. 9. 4 | and clinical asthma among 13- to 14-yr-old adolescents
95 II, 5. 10. 5 | Council Directive 2000/13/EC (European Commission,
96 II, 5. 10. 5 | in Council Directive 2000/13/EC (European Commission,
97 II, 5. 10. 7 | Commission (2000): Directive 2000/13/EC of the European Parliament
98 II, 5. 10. 7 | amending Directive 2000/13/EC as regards indication
99 II, 5. 10. 7 | Annex IIIa of Directive 2000/13/EC of the European Parliament
100 II, 5. 10. 7 | Annex IIIa to Directive 2000/13/EC of the European Parliament
101 II, 5. 10. 7 | J Gastroenterol Hepatol 13: 741-747.~Strannegard O
102 II, 5. 11. 3 | pierced skin has varied from 13 to 20% in the 1980s (B Larsson-Stymne
103 II, 5. 11. 3 | students increased from 13 to 39% during the 1985–1995
104 II, 5. 11. 3 | Contact Dermatitis,1985;13:289–293.~C Lidén, M Bruze,
105 II, 5. 11. 3 | rates of SCC increased by 13.5% in men and 18.8% in women.
106 II, 5. 11. 7 | Contact Dermatitis 1985;13:29-48.~ ~Levi F, Te VC,
107 II, 5. 12. 3 | where rates were around 10-13/100,000 men in the early
108 II, 5. 12. 3 | 2002, Finland from 7.4 to 13.6, Ireland from 3.4 to 4.
109 II, 5. 12. 3 | 12.5 to 19.4, Poland from 13.0 to 15.9, and mainly Hungary,
110 II, 5. 13 | 5.13. Overweight, obesity and
111 II, 5. 14. 3 | expenses. 245 169 dentists, 13 295 dental hygienists work
112 II, 5. 15. 1 | in other words, around 13.5 million people in the
113 II, 5. 15. 6 | Parliament and of the Council of 13 November 2007 on advanced
114 II, 6. 3. 4 | 2003–04 season in the other 13 countries. The highest consultation
115 II, 6. 3. 4 | corresponding to an overall rate of 13 per 100 000 per year, with
116 II, 6. 3. 5 | In 2005, a total of 13 207 cases were reported
117 II, 6. 3. 6 | of all cases. Lithuania (13.43 per 100 000 total population),
118 II, 6. 3. 6 | countries, with Ireland (13.75 per 100 000) and the
119 II, 7. 3. 4 | treated in hospital (Figure 7.13).~ ~Figure 7.13. Fatalities
120 II, 7. 3. 4 | Figure 7.13).~ ~Figure 7.13. Fatalities and injured
121 II, 8. 1. 2 | This survey covers only 13 Member States – the EU15
122 II, 8. 1. 5(3) | Nations' General Assembly on 13 of December 2006.~
123 II, 8. 2. 1 | SPID) in Finland was 0.13% based on the register of
124 II, 8. 2. 1 | participating countries (13 MS and 1 EEA country).~The
125 II, 8. 2. 1 | perspective. Eur J Public Health 13: 47-50; doi:10.1093/eurpub/
126 II, 8. 2. 1 | 47-50; doi:10.1093/eurpub/13.suppl_1.47~Walsh, P.N.,
127 II, 8. 2. 3 | Audiology 1996;Supplement 42:9-13~ ~Uimonen S, Huttunen K,
128 II, 9 | countries to a fifth of 13 year old boys in eight countries
129 II, 9. 1. 1 | Reprod Biol 2002;103(1):4-13.~Apgar V (1953): A t. Curr.
130 II, 9. 2. 2 | of adolescents aged 11, 13 and 15 years, who attend
131 II, 9. 2. 3 | symptoms” for children aged 13-14 for those countries which
132 II, 9. 2. 3 | rates of clinical asthma2 in 13- to 14-year-old children
133 II, 9. 2. 3(2) | previous 12-month period in 13- to 14-year-old children)
134 II, 9. 2. 4 | countries to a fifth of 13 year old boys in eight countries
135 II, 9. 2. 7 | Eurobarometer Issue No. 246 p 13. 9 November, 2006~ ~European
136 II, 9. 2. 7 | the field of health (2008-13), OJ No L 301, 20 November
137 II, 9. 3. 1 | attempt Demographic Research 13(15), pp 363-388~ ~Haslam,
138 II, 9. 3. 2 | Reprod Biol 2002;103(1):4-13.~ ~Ananth CV, Joseph KS,
139 II, 9. 3. 3 | pregnancy in the age group 13-19 years (Imamura M et al,
140 II, 9. 3. 3 | Encounter Module Project. May 13 2003. Available at: htt l (
141 II, 9. 4. 7 | of Public Health, Volume 13, No. 2 p. 56-61. March 2005~ ~
142 II, 9. 5. 3 | to police~Hungaryd~· 13% in/have been in a rela en
143 II, 9. 5. 3 | been drunk at the age of 13 or earlier. In Greece the
144 II, 9. 5. 6 | Available at:~htt p~(Accessed 13.07.07)~ ~Austbury J (2002):
145 II, 9. 5. 6 | Body and Society, 6(1), pp. 13-28.~ ~Risberg G, Hamber
146 II, 9. 5. 6 | of Public Health, Volume 13, No. 2 p. 56-61. March 2005~ ~
147 III, 10. 1. 3 | services. Recent Dev Alcohol 13:387-405.~Dahlgren, G. &
148 III, 10. 1. 3 | Acta Psychiatr Scand 113:13-22.~Szklo M (2000): Confounding
149 III, 10. 1. 3 | Germany. J Public Health 13(6):291-295.~Wiers RW, Sergeant
150 III, 10. 1. 3 | Acta Paediatr Suppl 404:9-13.~Wood PD (1994): Physical activity,
151 III, 10. 2. 1 | limit is at the ages from 13 - 20 years and the upper
152 III, 10. 2. 1 | Nearly 18% of Europeans aged 13 to 15 are smokers, more
153 III, 10. 2. 1 | in Ireland, but only 12%-13% of boys and 5%-7% of girls
154 III, 10. 2. 1 | EU though, over 1 in 8 (13%) of 15-16 year old students
155 III, 10. 2. 1 | by young men in Europe, 13,000 of whom die in the EU
156 III, 10. 2. 1 | European Region, Stockoholm 13-15 April 2005 [conference
157 III, 10. 2. 1 | ESPAD survey, between 1 and 13% (on average 4%) of school
158 III, 10. 2. 1 | for the first time when 13 years old or younger. Among
159 III, 10. 2. 1 | lifetime use of cannabis, 13% (3-20%) used it in the
160 III, 10. 2. 1 | more than once a day among 13 year old schoolchildren
161 III, 10. 2. 1 | among young people aged 11, 13 and 15 years HBSC studies
162 III, 10. 2. 1 | active children aged 11, 13 and 15 years, selected countries
163 III, 10. 2. 1 | are quoted in section ”5.13. Obesity, overweight and
164 III, 10. 2. 1 | Society of Health, 116:7-13.~ ~Gordon-Larsen P et al. (
165 III, 10. 2. 1 | weight and height in 11-, 13- and 15-year-old adolescents
166 III, 10. 2. 1 | subjects (22,924 women and 13,031 men) who participated
167 III, 10. 2. 1 | pre-obesity and obesity in the 13 and 15 year olds from the
168 III, 10. 2. 1 | indicating that up to 34% of 13-year-old boys versus 24%
169 III, 10. 2. 1 | overweight. Up to 9% of both 13-year-old and 15-year-old
170 III, 10. 2. 1 | obese, as were 5% of both 13-year-old and 15-year-old
171 III, 10. 2. 1 | Prevalence of overweight among 13-year-olds and 15-year-olds~ ~
172 III, 10. 2. 1 | overweight in adolescents aged 13-14 more than doubled from
173 III, 10. 2. 1 | labelling~ ~Directive 2000/13/EC on labelling, presentation
174 III, 10. 2. 1 | 2000b): Directive 2000/13/EC of the European Parliament
175 III, 10. 2. 4 | locus on chromosome 1p36.13 and a type 2 diabetes locus
176 III, 10. 2. 4 | metabolic syndrome. Obes Res, 13:2122-2131.~ ~Torhorst J,
177 III, 10. 3. 1 | Directive 96/29/Euratom (13 May 1996). However, the
178 III, 10. 3. 1 | of individual data from 13 European case-control studies.
179 III, 10. 3. 1 | Burden of Disease Series No 13. Geneva, World Health Organization, (
180 III, 10. 4. 2 | 5% (the Netherlands) and~13% (import) involving~incidents
181 III, 10. 4. 2 | 2000): Directive No. 2000/13/EC of the European Parliament
182 III, 10. 4. 2 | methods and approaches” 13-14 July 2006. 155.~ ~EFSA (
183 III, 10. 4. 2 | micro-organisms in food and feed. 13-14 December 2004. pp. 142.
184 III, 10. 4. 3 | that in these regions over 13 000 children aged under
185 III, 10. 4. 3 | populated country like Sweden, 13% of the population permanently
186 III, 10. 4. 4 | see Annex 1 of Chapter 5.13.~ ~The increasing production,
187 III, 10. 4. 5 | will be introduced over a 13 year period, starting in
188 III, 10. 5. 1 | information. Indoor Air, 13:53-64.~ DEFRA (2004): Review
189 III, 10. 5. 2 | Journal of Rural Health. 13(3), 253-256.~ ~Jones A,
190 III, 10. 5. 3 | and social conditions – 13/2006~ ~Current working conditions~
191 III, 10. 5. 3 | more frequent among women. 13% of all workers feared that
192 III, 10. 5. 3 | risk factors (table 10.5.3.13). Exposures to vibrations
193 III, 10. 5. 3 | working time.~ ~Table 10.5.3.13. Physical risks factors
194 III, 10. 6. 1 | four-year intervals among 11, 13 and 15 year old school children.
195 III, 10. 6. 1 | 11 year old girls, 65% of 13 year old girls and 61% of
196 III, 10. 6. 1 | the Netherlands, 92% of 13 year old girls, and in Slovenia,
197 III, 10. 6. 1 | 11 year old boys, 74% of 13 year old boys, and 69% of
198 III, 10. 6. 1 | 44% of boys, 78% of the 13 year old girls and 56% of
199 III, 10. 6. 1 | old Hungarian girls only 13% had used electronic contacts,
200 III, 10. 6. 1 | electronic contacts, among 13 year old Hungarian girls
201 IV, 11. 5. 3 | European countries~Figure 11.13. Exchanges and import/export
202 IV, 11. 5. 3 | place. For the living donor, 13 countries have binding criteria,
203 IV, 11. 6. 2 | are summarized in Table 11.13. Also in some countries,
204 IV, 11. 6. 2 | Mossialos 2008).~ ~Table 11.13. Examples for cost sharing
205 IV, 11. 6. 5 | in England." Euro Health 13(1): 13-16.~ ~Brook R, McGlynn
206 IV, 11. 6. 5 | England." Euro Health 13(1): 13-16.~ ~Brook R, McGlynn E
207 IV, 11. 6. 5 | Journal of Medicine 335(13): 966-970.~ ~Brook RH, McGlynn
208 IV, 11. 6. 5 | Journal Quality Health Care 13(6): 439-46.~ ~Evans RG,
209 IV, 11. 6. 5 | Project 3: Working Paper No. 13.~ ~McCarthy D, Blumenthal
210 IV, 11. 6. 5 | Protection Systems in the 13 Applicant Countries: Latvia
211 IV, 11. 6. 5 | Europe." Health Economics 13(7): 629-647.~ ~van Doorslaer
212 IV, 12. 1 | Treaty, formally adopted on 13 December 2007 in Lisbon,
213 IV, 12. 4 | Framework Programme (CIP) (2007-13)~ENV~LIFE - supporting environmental
214 IV, 12. 10 | high~Insurance public law 13 august 2004 : institution
215 IV, 12. 10 | 10March~Despacho nb 242/96 of 13 August~ -PERH – implementation
216 IV, 13 | 13.~THE WAY FORWARD~ ~
217 IV, 13. 1 | 13.1. Differences in selected
218 IV, 13. 1 | mortality data see Table 13.3). Large differences have
219 IV, 13. 1 | different EU countries.~ ~Table 13.1. Standardised Death Rates
220 IV, 13. 2 | 13.2. Assessing priorities
221 IV, 13. 2. 1 | 13.2.1. Disability adjusted
222 IV, 13. 2. 2 | 13.2.2. Burden of diseases~ ~
223 IV, 13. 2. 2 | disease in the OECD and 13% in non-OECD countries.~ ~
224 IV, 13. 2. 2 | dominate the picture (Figure 13.1).~ ~Figure 13.1. Patterns
225 IV, 13. 2. 2 | Figure 13.1).~ ~Figure 13.1. Patterns of total and
226 IV, 13. 2. 2 | population, EU25, EU15 (Table 13.4).~ ~Table 13.2. Global
227 IV, 13. 2. 2 | EU15 (Table 13.4).~ ~Table 13.2. Global burden of disease
228 IV, 13. 2. 2 | diseases are shown in Table 13.5.~ ~ ~Table 13.3. Additional
229 IV, 13. 2. 2 | in Table 13.5.~ ~ ~Table 13.3. Additional estimations
230 IV, 13. 2. 2 | ranks 1st and accounts for 13.7% of YLDs, followed by
231 IV, 13. 2. 3 | 13.2.3. Burden of diseases
232 IV, 13. 2. 3 | were estimated as follows: 13.2% of total disease burden
233 IV, 13. 2. 3 | range from 2-6%.~ ~Table 13.4. Burden of disease in
234 IV, 13. 2. 3 | three determinants in Table 13.6 are typically associated
235 IV, 13. 2. 3 | selected conditions. Table 13.7 presents a comparison
236 IV, 13. 2. 3 | diseases and depression. Table 13.7 also shows that the demonstrable
237 IV, 13. 2. 3 | different people.~ ~ ~Table 13.5. Annual health loss (in
238 IV, 13. 2. 4 | 13.2.4. Avoidable Burden of
239 IV, 13. 2. 4 | European countries (Table 13.8).~ ~ ~Table 13.6. WHO
240 IV, 13. 2. 4 | Table 13.8).~ ~ ~Table 13.6. WHO estimates for preventable
241 IV, 13. 2. 4 | the European Union (Table 13.6) are smoking, having a
242 IV, 13. 2. 4 | the data reported in Table 13.6 that these risk factors
243 IV, 13. 3 | 13.3. Demographic and socio-economic
244 IV, 13. 4 | 13.4. Migration policies~ ~
245 IV, 13. 5 | 13.5. Demands on healthcare
246 IV, 13. 6 | 13.6. Prioritising children’
247 IV, 13. 6. 1 | 13.6.1 Measurement of burden
248 IV, 13. 6. 2 | 13.6.2 Health Services for
249 IV, 13. 6. 2 | 13.6.2.1 Hospitals~ ~Children
250 IV, 13. 6. 2 | 13.6.2.2 Human Resources for
251 IV, 13. 6. 2 | 13.6.2.3 Primary Health Care
252 IV, 13. 6. 2 | 13.6.2.4 School Health and
253 IV, 13. 6. 2 | 13.6.2.5 Child Health Service
254 IV, 13. 6. 2 | 13.6.2.6 Pharmaceuticals for
255 IV, 13. 6. 3 | 13.6.3 Health Systems and Access
256 IV, 13. 7 | 13.7. Innovation~ ~Never before
257 IV, 13. 7. 1 | 13.7.1. “Innovation Cluster”
258 IV, 13. 7. 2 | 13.7.2. “Lead Market” initiative~ ~
259 IV, 13. 7. 2 | graduates, who now make up 13 per thousand 20-29 year
260 IV, 13. 7. 3 | 13.7.3. Research~ ~One of the
261 IV, 13. 7. 4 | 13.7.4. Ethical issues~ ~Ethical
262 IV, 13. 7. 5 | 13.7.5. Personal data protection
263 IV, 13. 8 | 13.8. Civil society involvement
264 IV, 13. 9 | 13.9. References~ ~Andlin-Sobocki
265 IV, 13. 9 | Journal of Public Health, 13, 3, Supplement, 38-46.~ ~
|
|
| |
